Table 1.
Characteristics of patients (n = 85).
| Mean age | 50 years | 21–70 |
| Mean CA 125 before SLL |
1879 UI/mL | 21–31599 |
| FIGO stage | II | 13 (15%) |
| III | 63 (74%) | |
| IV | 9 (11%) | |
| Histological types | Serous | 57 (67.1%) |
| Endometrial | 11 (12.9%) | |
| Mucinous | 4 (4.7%) | |
| Mixed | 4 (4.7%) | |
| Unclassified types | 9 (10.6%) | |
| Grade | I | 3 (3.5%) |
| II | 12 (14.1%) | |
| III | 14 (16.5%) | |
| Optimal cytoreduction after primary surgery (R < 1 cm) | FIGO II–IV | 55 (64.7%) |
| Type of primary chemotherapy | Cisplatin-cyclophosphamide | 68 (70%) |
| Carboplatin-paclitaxel | 17 (30%) | |
| SLL duration | 120.1 min | 45–240 min |
| Hospital stay after SLL | 8.5 days | 5–26 |